Remove 2019 Remove Cannabis Remove Epilepsy Remove Treatment
article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)

article thumbnail

GW’s Cannabis-Based Epilepsy Drug Set For European Approval

Cannabis Law Report

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. Knowledge, attitudes and policies regarding medical cannabis and cannabis-based drugs are changing. Cannabidiol-based treatment receives marketing approval from EMA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Georgia Medical Cannabis Patients Can Now Purchase Cannabis Oil From Pharmacies

Veriheal

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets. Its conversion into low-THC cannabis oil also allowed for treating many diseases.

Oil 97
article thumbnail

The Week in Weed: November 29, 2019

The Blunt Truth

Not everyone in the Sunshine State is in favor of legal cannabis, however. Substance Abuse and Mental Health Services Administration has prohibited the use of medical marijuana as a treatment for opioid addiction. The 15% tax rate will remain the same, but it will be based on a markup rate of 80%, rather than the current 60%.

Hemp 79
article thumbnail

Insys Development Company, Inc. v. GW Pharma Limited Co., Case No. IPR2017-00503 – PTAB Only Partially Smokes Cannabis Patent

Cannabis Law Report

January 2019. Eleven of thirteen cannabis patent claims survive PTAB challenge. s patent directed to the use of cannabinoids, including cannabidiol (“CBD”), in the treatment of certain types of epilepsy. Sterne, Kessler, Goldstein & Fox P.L.L.C. Insys Development Company, Inc. i] Insys Development Company, Inc.

article thumbnail

Cannabinoids for Tinnitus?

Project CBD

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. Among the 45 respondents, median age 55, only 10 said they were current cannabis users (19 had never used, and 16 had used in the past).

article thumbnail

Cannabis laws in Guatemala

The Cannigma

Medical: limited Recreational: illegal Guatemala is a country in Central America that has been the subject of intense debate over its cannabis laws. Cannabis is not legal in Guatemala. Despite its illegal status, cannabis use is widespread in Guatemala, particularly among young people.

Law 52